Liu Bing, Yu Ying, Liu Wen, Deng Tuo, Xiang Daoman
Department of Ophthalmology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
Front Med (Lausanne). 2021 Oct 4;8:618353. doi: 10.3389/fmed.2021.618353. eCollection 2021.
We conducted a meta-analysis to explore all the potential risk factors for non-arteritic anterior ischemic optic neuropathy (NAION) based on the published literature. A comprehensive literature search through the online databases was performed to obtain studies concerning the risk factors of NAION up to June 2020. Pooled unadjusted odds ratios (s) or rate ratios (s) were calculated to evaluate the weight of risk factors. This study was registered in PROSPERO under the number CRD42018084960. Our meta-analysis included 49 original studies comprising of more than 10 million patients. The following risk factors were proved to be significantly associated with NAION: male gender ( = 1.67, 95% : 1.50-1.85, < 0.00001), hypertension ( = 1.28, 95% : 1.20-1.37, < 0.00001), hyperlipidemia ( = 1.43, 95% : 1.26-1.62, < 0.00001), diabetes mellitus (DM) ( = 1.53, 95% : 1.36-1.73, < 0.00001), coronary heart disease (CHD) ( = 1.68, 95% : 1.24-2.27, = 0.0008), sleep apnea ( = 3.28, 95% : 2.08-5.17, < 0.00001), factor V Leiden heterozygous ( = 2.21, 95% : 1.19-4.09, = 0.01), and medication history of cardiovascular drugs. We concluded that the above risk factors were significantly related to NAION. Better understanding of these risk factors in NAION can help the direct therapeutic approaches.
我们基于已发表的文献进行了一项荟萃分析,以探究非动脉炎性前部缺血性视神经病变(NAION)的所有潜在风险因素。通过在线数据库进行了全面的文献检索,以获取截至2020年6月有关NAION风险因素的研究。计算合并的未调整优势比或率比,以评估风险因素的权重。本研究已在国际前瞻性系统评价注册库(PROSPERO)注册,注册号为CRD42018084960。我们的荟萃分析纳入了49项原始研究,涉及超过1000万患者。以下风险因素被证明与NAION显著相关:男性(优势比=1.67,95%置信区间:1.50-1.85,P<0.00001)、高血压(优势比=1.28,95%置信区间:1.20-1.37,P<0.00001)、高脂血症(优势比=1.43,95%置信区间:1.26-1.62,P<0.00001)、糖尿病(DM)(优势比=1.53,95%置信区间:1.